Abstract
Introduction
This study evaluated the association between prefecture-level achievement of chronic kidney disease-mineral and bone disorder (CKD-MBD) parameter targets and mortality in Japanese dialysis patients.
Materials and methods
We conducted an ecological study of all prefectures in Japan using data from the Japanese Society of Dialysis Therapy and National Vital Statistics between 2016 and 2017. We calculated adherence rates to recommend target ranges for CKD-MBD parameters, including phosphate, corrected calcium, and parathyroid hormone (PTH), and explored associations of these rates with prefecture-specific standardized mortality rates (SMRs) among the general population and among prevalent dialysis patients using bivariate association analysis and structural equation modeling.
Results
Prefecture-level adherence to the target phosphate range was significantly and negatively associated with prefecture-specific SMRs in men (standardized estimate (β) = − 0.61, p < 0.001) and women (β = − 0.41, p < 0.001). However, prefecture-level adherence to the target corrected calcium range was significantly and negatively associated with prefecture-specific SMRs only in men (β = − 0.28, p = 0.01). Meanwhile, prefecture-level adherence to the target PTH range was significantly and positively associated with prefecture-specific SMRs in men (β = 0.23, p = 0.04). Prefecture-level SMRs of females in the general population had a significant impact on prefecture-level SMRs of female dialysis patients (β = 0.27, p = 0.03). The models explained 52% of variance in SMR for men and 33% for women.
Conclusion
A higher prefecture-level achievement rate of the target phosphate range recommended by the Japanese CKD-MBD guidelines was associated with a lower prefecture-specific SMR in the Japanese dialysis population.
Similar content being viewed by others
References
Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218
Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771–780
Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519–530
Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC, Investigators ARO (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26:1948–1955
Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, Committee of renal data registry of the Japanese society for dialysis therapy (2013) Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial 17:221–228
Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I (2019) Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study. Nephrol Dial Transplant 34:1207–1216
Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int 92:26–36
Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247–288
Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M (2004) Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 44:34–38
Fouque D, Roth H, Darné B, Jean-Bouchet L, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM, Phosphorus F, Observatory C (2018) Achievement of kidney disease: improving global outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the photo-graphe3 study. Clin Kidney J 11:73–79
Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, Netherlands cooperative study on the adequacy of dialysis (NECOSAD) study group (2005) The kidney disease outcomes quality initiative (K/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 46:925–932
Palomares I, Ramos R, Martin-Malo A, Merello JI, Praga M, Luño J, de Francisco AL, ORD Group (2013) Compliance with mineral metabolism targets in haemodialysis patients: moving backwards? Blood Purif 36:131
Furumatsu Y, Nagasawa Y, Yamamoto R, Iio K, Iwatani H, Matsui I, Takabatake Y, Kawada N, Shoji T, Imai E, Isaka Y, Rakugi H (2010) Specialist care and improved long-term survival of dialysis patients. Nephrol Dial Transplant 25:1930–1935
Ogata S, Yorioka N (2011) Environmental factors influencing the survival of chronic dialysis patients. Clin Exp Nephrol 15:405–409
Ogata S, Nishi S, Wakai K, Hanafusa N, Iseki K, Tsubakihara Y, Masakane I (2015) Institutional factors influencing regional differences in the 1-year survival of dialysis patients. Hemodial In 19:S5–S10
Wakasugi M, Narita I (2021) Structural equation modeling assessment of the impact of dialysis facility staffing on mortality: an ecological study. Jpn J Nephrol 63:179–186 ((in Japanese))
Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL et al (2006) International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 17:3510–3519
Suzuki E, Kashima S, Kawachi I, Subramanian SV (2012) Geographic inequalities in all-cause mortality in Japan: compositional or contextual? PLoS ONE 7:e39876
Masakane I, Taniguchi M, Nakai S, Tsuchida K, Wada A, Ogata S, Hasegawa T, Hamano T, Hanafusa N, Hoshino J, Goto S, Yamamoto K, Minakuchi J, Nakamoto H, On behalf of Japanese Society for Dialysis Therapy Renal Data Registry Committee (2018) Annual dialysis data report 2016. JSDT Ren Data Regist Ren Replace Ther 4:45
Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Goto S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H, on behalf of Japanese society for dialysis therapy renal data registry committee (2019) Annual dialysis data report 2017. JSDT Ren Data Regist Ren Replace Ther 5:53
Wakasugi M, Narita I (2022) Sex differences in cause-specific mortality in Japanese dialysis patients. Intern Med. https://doi.org/10.2169/internalmedicine.8981-21
Wakasugi M, Kawamura K, Yamamoto S, Kazama JJ, Narita I (2012) High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial 16:226–231
Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I (2013) Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan. Ther Apher Dial 17:298–304
Wakasugi M, Matsuo K, Kazama JJ, Narita I (2015) Higher mortality due to intracerebral hemorrhage in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial 19:45–49
Wakasugi M, Kazama JJ, Narita I (2016) Mortality trends among Japanese dialysis patients, 1988–2013: a joinpoint regression analysis. Nephrol Dial Transplant 31:1501–1507
Schober P, Boer C, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth Analg 126:1763–1768
Hooper DCJ, Mullen MR (2008) Equation modelling: guidelines for determining model fit. Electron J Bus Res Methods 6:53–60
Itaya T, Shimizu S, Hara T, Matsuoka Y, Fukuhara S, Yamamoto Y (2021) Association between facility-level adherence to phosphorus management guidelines and mortality in haemodialysis patients: a prospective cohort study. BMJ Open 11:e051002
Kakuta T, Ishida M, Fukagawa M (2018) Critical governance issue of parathyroid hormone assays and its selection in the management of chronic kidney disease mineral and bone disorders. Ther Apher Dial 22:220–228
Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H et al (2012) Japanese society for dialysis therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial 16:435
Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T (2012) 2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients. Ther Apher Dial 16:289–310
Kukita K, Ohira S, Amano I, Naito H, Azuma N, Ikeda K, Kanno Y, Satou T, Sakai S, Sugimoto T, Takemoto Y, Haruguchi H, Minakuchi J, Miyata A, Murotani N, Hirakata H, Tomo T, Akizawa T, Vascular access construction and repair for chronic hemodialysis guideline working group, Japanese society for dialysis therapy (2015) 2011 update Japanese society for dialysis therapy guidelines of vascular access construction and repair for chronic hemodialysis. Ther Apher Dial 19:39
Watanabe Y, Yamagata K, Nishi S, Hirakata H, Hanafusa N et al (2015) Japanese society for dialysis therapy clinical guideline for “hemodialysis initiation for maintenance hemodialysis.” Ther Apher Dial 19:107
Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, Hattori M, Suzuki T, Morita S, Ashida A, Ito Y, Kuragano T, Komatsu Y, Sakai K, Tsubakihara Y, Tsuruya K, Hayashi T, Hirakata H (2017) 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther 3:36
Isaka Y, Hamano T, Fujii H, Tsujimoto Y, Koiwa F, Sakaguchi Y, Tanaka R, Tomiyama N, Tatsugami F, Teramukai S (2021) Optimal phosphate control related to coronary artery calcification in dialysis patients. J Am Soc Nephrol 32:723–735
Acknowledgements
We thank the committee of the renal data registry of the Japanese Society for Dialysis Therapy (JSDT) for permission to use their registry data. The results in the current study were derived from split data from the WADDA system of the JSDT by the authors. However, the interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as the official policy or interpretation of the JSDT.
Funding
This work was supported by a research grant from JSPS KAKENHI (Grants-in-Aid for Scientific Research, Grant Number JP18K08202) to MW. No funding agency had any role in the study design, collection, analysis and interpretation of data, writing the report, and the decision to submit the report for publication.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation and data collection and analysis were performed by MW and IN. The first draft of the manuscript was written by MW and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no relevant financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Wakasugi, M., Narita, I. Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological study. J Bone Miner Metab 40, 810–818 (2022). https://doi.org/10.1007/s00774-022-01351-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-022-01351-5